Bacterial Vaginosis and Trichomononiasis. Fundamental World Guidelines on Management and Therapy of the Patients
Abstract
The vaginal discharge is one of the most frequent symptoms requiring medical advise. Vaginal discharges are mainly associated with three diseases: bacterial vaginosis, trichomononiasis and candidiasis. The review is concerned with up-to-date approaches to the treatment of females with bacterial vaginosis and trichomononiasis, diseases different by the etiology and pathogenesis, but at the same time similar with respect to the treatment. The analysis is in compliance with the principles of the two fundamental world guidelines.
About the Author
M. A. Gomberg
A.I. Evdokimov Moscow State Medical Stomatologic University; Moscow Research and Practical Centre of Dermatovenerology and Cosmethology
Russian Federation
Russian Federation
References
1. Centers for Disease Control and Prevention. Diseases Characterized by Vaginal Discharge. MMWR 2010; 59: 12: 56-63
2. Sherrard J., Donders G., White D., Skov Jensen J.S. European (IUSTI/WHO) guideline on the management of vaginal discharge. Int J STD AIDS 22: 8: 421-429.
3. Hale L.P., Swidsinski A., Mendling W. Bacteria associated with bacterial vaginosis. N Engl J Med 2006; 354: 202-203.
4. Oliveira F.A., Pfleger V., Lang K. et al. Sexually transmitted infections, bacterial vaginosis, and candidiasis in women of reproductive age in rural North-East Brazil: a population-based study. Mem Inst Oswaldo Cruz. 2007; 102 (6): 751-756.
5. Fang X., Zhou Y., Yang Y., Diao Y., Li H. Prevalence and risk factors of trichomoniasis, bacterial vaginosis, and candidiasis for married women of child-bearing age in rural Shandong. Jpn J Infect Dis 2007; 60 (5): 257-261.
6. Koumans E.H., Sternberg M., Bruce C. et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 2007; 34 (11): 864-869.
7. Dan M., Kaneti N., Levin D., Poch F., Samra Z. Vaginitis in a gynecologic practice in Israel: causes and risk factors. Isr Med Assoc J 2003; 5 (9): 629-632.
8. Bickley L.S., Krisher K.K., Punsalang A. et al. Comparison of direct fluorescent antibody, acridine orange, wet mount and culture for detection of Trichomonas vaginalis in women attending a public sexually transmitted disease clinic. Sex Trans Dis 1989; 127-131.
9. Gelbart S.M., Thomason J.L., Osypowski et al. Growth of Trichomonas vaginalis in commercial culture media. J. Clin. Microbiol 1990; 28, 962-964.
10. Madico G., Quinn T.C., Rompalo A. et al. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 1998; 36: 3205-3210.
11. Crucitti T., Van Dyck E., Tehe A. et al. Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in selfcollected swab specimens. Sex Transm Infect 2003; 79: 393-398.
12. Landers D.V., Wiesenfeld H.C., Heine R.P. et al. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol 2004; 190 (4): 1004-1010.
13. Amsel R., Totten P.A., Spiegel C.A. et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74 (1): 14-22.
14. Ison C.A., Hay P.E. Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm. Infect 2002; 78 (6): 413-415.
15. Nugent R.P., Krohn M.A., Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29 (2): 297-301.
16. Oduyebo O.O., Anorlu R.I., Ogunsola F.T. The effects of antimicrobial therapy on bacterial vaginosis in nonpregnant women. Cochrane Database Syst Rev 2009; 3: CD006055.
17. Schindler E.M., Thamm H., Ansmann E.B. et al. Treatment of bacterial vaginitis. Multicenter, randomized, open study with tinidazole in comparison with metronidazole. Fortschr Med 1991; 109 (5): 138-140.
18. Voorspoels J., Casteels M., Remon J.P., Temmerman M. Local treatment of bacterial vaginosis with a bioadhesive metronidazole tablet. Eur J Obstet Gynecol Reprod Biol 2002; 105 (1): 64-66.
19. Hanson J.M., McGregor J.A., Hillier S.L. et al. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med 2000; 45 (11): 889-896.
20. Brandt M., Abels C., May T. et al. Intravaginally applied metronidazole is as effective as orally applied in the treatment of bacterial vaginosis, but exhibits significantly less side effects. Eur J Obstet Gynecol Reprod Biol 2008; 141 (2): 158-162.
21. Paavonen J., Mangioni C., Martin M.A., Wajszczuk C.P. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet Gynecol 2000; 96 (2): 256-260.
22. Mikamo H., Kawazoe K., Izumi K. Comparative study on vaginal or oral treatment of bacterial vaginosis. Chemotherapy 1997; 43 (1): 60-68.
23. Schwebke J.R., Desmond R.A. A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis. Clin Infect Dis 2007; 44 (2): 213-219.
24. Schwebke J.R., Desmond R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol 2007; 196: 517-516.
25. Das S., Huegnsberg M., Shahmanesh M. Treatment failure of vaginal tri-chomonisis in clinical practice. Intl J STD & AIDS. 2005; 16: 284-286.
26. Crowell A.L., Sanders-Lewis K.A., Secor W.E. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrobial Agents and Chemotherapy 2003; 47: 1407-1409.
27. Sobel J.D., Nyirjesy P., Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clinical Infectious Diseases 2001; 33: 1341-1346.
28. Mannen-Tobin A., Wilson J.D. Management of metronidazole-resistant Trichomonas vaginalis - a new approach. Intl J STD & AIDS 2005; 16: 488-490.
29. Sobel J.D., Ferris D., Schwebke J. et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006; 194 (5): 1283-1289.
30. Marcone V., Calzolari E., Bertini M. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. New Microbiol 2008; 31 (3): 429-433.
31. Simoes J.A., Bahamondes L.G., Camargo R.P. et al. A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. Br J Clin Pharmacol 2006; 61 (2): 211-217.
32. Kissinger P., Schmidt N., Mohammed H. et al. Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex Transm Dis 2006; 33: 445-450.
33. Schwebke J.R., Desmond R.A. A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women. Sex Transm Dis 2010; 37: 392-396.
34. Lyng J., Christensen J. A double blind study of treatment with a single dose tinidazole of partners to females with trichomoniasis. Acta Obstet Gynecol Scand 1981; 60: 199-201.
35. Dykers J.R. Single dose metronidazole treatment for trichomonal vaginitis - patient and consort. N Eng J Med 1975; 293; 23-24.
36. Klebanoff M.A., Carey J.C., Hauth J.C. et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001; 345: 487-493.
37. Kigozi G.G., Brahmbhatt H., Wabwire-Mangen F. et al. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2003; 189: 1398-1400.
38. Burtin P., Taddio A., Adburnu O. et al. Safety of metronidazole in pregnancy: a metaanalysis. Am J Obstet Gynecol 1995; 172: 525-529.
39. Czeizel A.E., Rockenbauer M. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 1998; 105: 322-327.
40. Caro-Paton T., Carvajal A., de Diego I.M. et al. Is metronidazole teratogenic: a meta-analysis. Br J Clin Pharmacol 1997; 44: 179-182.
41. Burtin P., Taddio A., Ariburnu O. et al. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995; 172: 2 (1): 525-529.
42. Piper J.M., Mitchel E.F., Ray W.A. Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol 1993; 82: 348-352.
43. Ugwumadu A., Reid F., Hay P. et al. Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin. Obstet Gynecol 2004; 104: 114-119.
44. Hauth J.C., Goldenberg R.L., Andrews W.W. et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995; 333: 1732-1736.
45. Morales W.J., Schorr S., Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994; 171: 345-347.
46. Kurohara M.L., Kwong F.K., Lebherz T.B., Klaustermeyer W.B. Metronidazole hypersensitivity and oral desensitization. J Allergy Clin Immunol 1991; 88: 279-280.
47. Pearlman M. D., Yashar C., Ernst S. et al. An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reaction to metronidazole. Am J Obstet Gynecol 1996; 174: 934-936.
48. Helms D.J., Mosure D.J., Secor W.E. et al. Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol 2008; 198: 370-377.
49. Schmid G., Narcisi E., Mosure D. et al. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med 2001; 46: 545-549.
50. Schwebke J.R., Barrientes F.J. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother 2006; 50: 4209-4210.
51. Падейская Е.H. 5-Нитроимидазолы - антимикробные препараты для лечения бактериальных и протозойных инфекций. Consilium-Midicum 2004; 6: 1.
Review
For citations:
Gomberg M.A. Bacterial Vaginosis and Trichomononiasis. Fundamental World Guidelines on Management and Therapy of the Patients. Antibiot Khimioter = Antibiotics and Chemotherapy. 2013;58(1-2):19-26. (In Russ.)
Views:
364
Email this article 